Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Comment by Bigboyoneon Oct 27, 2016 1:25pm
113 Views
Post# 25393603

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TRX

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TRXGolden- Not sure if your reply was directed to me, or the board in general.
I still Agree to Disagree-
I read your posts and yes, many things you said I agree with, but your point is? I really dont know what your point is? are you unhappy with the stock itself? Are you in our soon selling? Its your choice.
I hate to break it to you gone are the days when, the SP price was based on EXPECTED or POTENTIAL earnings. Sure I would like to see $15.00 here, and I think that would be a fair valuation considing the plus"s.
You dont have to point out to me Vimovo sales numbers are dropping...I already know we have not earnings, and yes, I know, we are mired in debt..but I want to 1. Trust Adams, for his past record. 2. a Hungry new sales force of over a 100 workers. 2. Taking a few dead products, that where not worth a bigger Mfg's time to market or push with their own sales force. 3. Yosprala's approval.
Which is actually one of the white knight products in the Bio med, field, its cheap,reasonable, its obtainable (CVS going to have it Jan 1st), and if it even comes with discount coupons if you cant afford it.
We are in tax loss selling season, & yes, Deerfield and other  Hedgies are probably shorting, but only to buy back at a later date.Short Interest has risen since September, its a given, and on paper...I have seen it before, and with all your expertise and margin account advice you cannot as a small investor "short" a stock under $5.00, especially if you are working with a discount brokerage. Its a risk to them. If you are a large qualified investor (Mil +$ )with a ton of dough at say a large brokerage, they may throw you a bone and let you short a few shares in the box/house.
I would suggest if you feel you are not getting your due..write some Option calls..
otherwise, not sure what your griping about? Not many on this site are in the black, or if they are its no home run..but I think 2017 will be better and 2018 will be even better then that.
<< Previous
Bullboard Posts
Next >>